Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-02-24 @ 10:55 AM
Study NCT ID:
NCT03787251
Status:
WITHDRAWN
Last Update Posted:
2022-04-19
First Post:
2018-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-20
First Submit QC Date:
None
Study First Post Date:
2018-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-11
Last Update Post Date:
2022-04-19
Last Update Post Date Type:
ACTUAL